Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.38.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.494NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.167NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.267NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-211.894South Korea
B.1.165NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.554NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.243.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.5.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.450NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.130NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.444NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-3484.59South Korea
AW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.268NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.344NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.103NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.485NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.119NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.276NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.111NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.336NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.400.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.537NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-3484.59South Korea
B.1.548NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.24.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.492NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.540NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.487NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.118NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.501NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.226NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.546NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.194NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.429.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.9 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.25.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.203NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.157NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.176NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.3.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.391NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.393NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.432NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.388NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used